Drugs / WSD0628
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05917145 | Jan 2024 → May 2028 expected | glioblastoma | Mayo Clinic | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WSD-0628 | “WSD-0628 radio sensitizes Glioblastoma cells.” NCT05917145 ↗ |
| Action | Inhibit | “a small molecule ATM inhibitor” NCT05917145 ↗ |
| Modality | Small molecule | “a small molecule ATM inhibitor” NCT05917145 ↗ |
| Target | ATM | “a small molecule ATM inhibitor” NCT05917145 ↗ |